Dimitrova Yoana N, Gutierrez Jemy A, Huard Kim
Genentech 1 DNA Way South San Francisco CA 94080 USA
Pfizer 1 Portland Street Cambridge MA 02139 USA.
RSC Med Chem. 2022 Oct 27;14(1):22-46. doi: 10.1039/d2md00212d. eCollection 2023 Jan 25.
An arsenal of molecular tools with increasingly diversified mechanisms of action is being developed by the scientific community to enable biological interrogation and pharmaceutical modulation of targets and pathways of ever increasing complexity. While most small molecules interact with the target of interest in a 1 : 1 relationship, a noteworthy number of recent examples were reported to bind in a sub-stoichiometric manner to a homomeric protein complex. This approach requires molecular understanding of the physiologically relevant protein assemblies and in-depth characterization of the compound's mechanism of action. The recent literature examples summarized here were selected to illustrate methods used to identify and characterize molecules with such mechanisms. The concept of one small molecule targeting a homomeric protein assembly is not new but the subject deserves renewed inspection in light of emerging technologies and increasingly diverse target biology, to ensure relevant systems are used and valuable compounds with potentially novel sub-stoichiometric mechanisms of action aren't overlooked.
科学界正在开发一系列作用机制日益多样化的分子工具,以实现对越来越复杂的靶点和信号通路进行生物学探究和药物调控。虽然大多数小分子以1:1的关系与目标靶点相互作用,但最近有相当数量的例子表明,它们以亚化学计量的方式与同聚体蛋白复合物结合。这种方法需要对生理相关的蛋白质组装体有分子层面的理解,并深入表征化合物的作用机制。此处总结的近期文献实例旨在说明用于鉴定和表征具有此类作用机制的分子的方法。一个小分子靶向同聚体蛋白组装体的概念并不新鲜,但鉴于新兴技术和日益多样化的靶点生物学,这个主题值得重新审视,以确保使用相关系统,且具有潜在新型亚化学计量作用机制的有价值化合物不被忽视。